Last 12 months
Inside the activity.
5 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2022 Filed Aug 4, 2022 00:17 UTC |
Peterson Neil W.CHIEF OPERATING OFFICER
|
SaleCommon Stock | 4,000 | $58.10 | $232,400.00 |
DisclosureSEC source: 0001415889-22-008213 · form4-08032022_050850.xml · nonDerivative · entry 2 Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.64 to $60.99, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 01, 2022 Filed Aug 4, 2022 00:17 UTC |
Peterson Neil W.CHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock | 4,000 | $16.05 | $64,200.00 |
DisclosureSEC source: 0001415889-22-008213 · form4-08032022_050850.xml · nonDerivative · entry 1 Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 23:34 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0001415889-22-006232 · form4-06072022_040630.xml · derivative · entry 3 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 23:34 UTC |
Millner F. Ann Ed.D.Director
|
SaleCommon Stock, No Par Value | 6,378 | $61.92 | $394,925.76 |
DisclosureSEC source: 0001415889-22-006232 · form4-06072022_040630.xml · nonDerivative · entry 2 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,698 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.900 to $61.985, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 23:34 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionCommon Stock, No Par Value | 10,000 | $18.80 | $188,000.00 |
DisclosureSEC source: 0001415889-22-006232 · form4-06072022_040630.xml · nonDerivative · entry 1 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2022 Filed May 26, 2022 23:02 UTC |
ANDERSON A SCOTTDirector
|
GrantCommon Stock, No Par Value | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005736 · form4-05262022_040528.xml · nonDerivative · entry 1 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,135 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 24, 2022 Filed May 26, 2022 22:59 UTC |
Carpenter Lonny J.Director
|
Grantcomm | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005732 · form4-05262022_030527.xml · nonDerivative · entry 1 Carpenter Lonny J · CIK 0001451534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,522 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 24, 2022 Filed May 26, 2022 22:51 UTC |
Gunderson Thomas J.Director
|
GrantCommon Stock, No Par Value | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005730 · form4-05262022_030534.xml · nonDerivative · entry 1 Gunderson Thomas James · CIK 0001708144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,152 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 24, 2022 Filed May 26, 2022 22:55 UTC |
Evans Stephen C.Director
|
GrantCommon Stock, No Par Value | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005731 · form4-05262022_030509.xml · nonDerivative · entry 1 Evans Stephen C. · CIK 0001844301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,964 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 24, 2022 Filed May 26, 2022 22:48 UTC |
Millner F. Ann Ed.D.Director
|
GrantCommon Stock, No Par Value | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005728 · form4-05262022_030529.xml · nonDerivative · entry 1 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,076 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 24, 2022 Filed May 26, 2022 22:50 UTC |
Hogan James T.Director
|
GrantCommon Stock, No Par Value | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005729 · form4-05262022_030520.xml · nonDerivative · entry 1 Hogan James T. · CIK 0001816127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,152 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 24, 2022 Filed May 26, 2022 22:43 UTC |
Ward Lynne N.Director
|
GrantCommon Stock, No Par Value | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005726 · form4-05262022_030539.xml · nonDerivative · entry 1 Ward Lynne · CIK 0001786127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,549 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 24, 2022 Filed May 26, 2022 22:36 UTC |
Kaiser Laura S.Director
|
GrantCommon Stock, No Par Value | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005725 · form4-05262022_030514.xml · nonDerivative · entry 1 Kaiser Laura S. · CIK 0001726511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 24, 2022 Filed May 26, 2022 22:35 UTC |
Floyd DavidDirector
|
GrantCommon Stock, No Par Value | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005724 · form4-05262022_030501.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,152 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 24, 2022 Filed May 26, 2022 22:33 UTC |
McDonnell Michael R.Director
|
GrantCommon Stock, No Par Value | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005723 · form4-05262022_030527.xml · nonDerivative · entry 1 MCDONNELL MICHAEL R · CIK 0001121897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| March 30, 2022 Filed Aug 15, 2022 22:42 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
GiftCommon Stock, No Par Value | 640 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-008641 · form4-08152022_030843.xml · nonDerivative · entry 5 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,894 Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 01:18 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
Tax withholdingCommon Stock, No Par Value | 1,942 | $65.03 | $126,288.26 |
DisclosureSEC source: 0001415889-22-002086 · form4-03012022_050326.xml · nonDerivative · entry 2 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,031 Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 01:13 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
Tax withholdingCommon Stock, No Par Value | 1,942 | $65.03 | $126,288.26 |
DisclosureSEC source: 0001415889-22-002085 · form4-03012022_050344.xml · nonDerivative · entry 2 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,534 Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 01:10 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock, No Par Value | 1,942 | $65.03 | $126,288.26 |
DisclosureSEC source: 0001415889-22-002083 · form4-03012022_050324.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,144 Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 01:03 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Tax withholdingCommon Stock, No Par Value | 1,942 | $65.03 | $126,288.26 |
DisclosureSEC source: 0001415889-22-002082 · form4-03012022_050349.xml · nonDerivative · entry 2 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,031 Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 01:01 UTC |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
Tax withholdingCommon Stock, No Par Value | 7,832 | $65.03 | $509,314.96 |
DisclosureSEC source: 0001415889-22-002081 · form4-03012022_050303.xml · nonDerivative · entry 2 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 977,764 Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:18 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
GrantNon-qualified stock options (right to buy) · Derivative | 8,094 | $0.00 Strike: $65.03 | $0.00 |
DisclosureSEC source: 0001415889-22-002086 · form4-03012022_050326.xml · derivative · entry 3 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 Underlying: Common Stock · 8,094 shares Expires 2029-02-28 F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:18 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
GrantCommon Stock, No Par Value | 6,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002086 · form4-03012022_050326.xml · nonDerivative · entry 1 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,973 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:11 UTC |
Voigt Michel J.CHIEF HUMAN RESOURCES OFFICER
|
GrantNon-qualified stock options (right to buy) · Derivative | 8,094 | $0.00 Strike: $65.03 | $0.00 |
DisclosureSEC source: 0001415889-22-002084 · form4-03012022_050342.xml · derivative · entry 2 Voigt Michel James · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 Underlying: Common Stock · 8,094 shares Expires 2029-02-28 F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:13 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
GrantNon-qualified stock options (right to buy) · Derivative | 8,094 | $0.00 Strike: $65.03 | $0.00 |
DisclosureSEC source: 0001415889-22-002085 · form4-03012022_050344.xml · derivative · entry 3 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 Underlying: Common Stock · 8,094 shares Expires 2029-02-28 F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:13 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
GrantCommon Stock, No Par Value | 6,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002085 · form4-03012022_050344.xml · nonDerivative · entry 1 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,476 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:10 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
GrantNon-qualified stock options (right to buy) · Derivative | 8,094 | $0.00 Strike: $65.03 | $0.00 |
DisclosureSEC source: 0001415889-22-002083 · form4-03012022_050324.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 Underlying: Common Stock · 8,094 shares Expires 2029-02-28 F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:10 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
GrantCommon Stock, No Par Value | 6,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002083 · form4-03012022_050324.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,086 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:03 UTC |
Parra Raul Jr.CFO AND TREASURER
|
GrantNon-qualified stock options (right to buy) · Derivative | 14,570 | $0.00 Strike: $65.03 | $0.00 |
DisclosureSEC source: 0001415889-22-002082 · form4-03012022_050349.xml · derivative · entry 4 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,570 Underlying: Common Stock · 14,570 shares Expires 2029-02-28 F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:03 UTC |
Parra Raul Jr.CFO AND TREASURER
|
GrantCommon Stock, No Par Value | 6,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002082 · form4-03012022_050349.xml · nonDerivative · entry 1 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,973 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:01 UTC |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
GrantNon-qualified stock options (right to buy) · Derivative | 48,566 | $0.00 Strike: $65.03 | $0.00 |
DisclosureSEC source: 0001415889-22-002081 · form4-03012022_050303.xml · derivative · entry 6 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,566 Underlying: Common Stock · 48,566 shares Expires 2029-02-28 F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 2/28/2023. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:01 UTC |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
GrantCommon Stock, No Par Value | 17,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002081 · form4-03012022_050303.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 985,596 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020. Read SEC document |
| December 28, 2021 Filed Feb 14, 2022 16:27 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
GiftCommon Stock, No Par Value | 1,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-001253 · form5-02142022_080224.xml · nonDerivative · entry 1 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,846 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:52 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 16,364 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001415889-21-004419 · form4-09162021_040923.xml · derivative · entry 6 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 16,364 shares Expires 2024-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing on 04/14/2018. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:52 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
SaleCommon Stock, No Par Value | 15,546 | $71.88 | $1,117,446.48 |
DisclosureSEC source: 0001415889-21-004419 · form4-09162021_040923.xml · nonDerivative · entry 4 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,696 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.75 to $72.02, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:52 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
Exercise / conversionCommon Stock, No Par Value | 16,364 | $28.20 | $461,464.80 |
DisclosureSEC source: 0001415889-21-004419 · form4-09162021_040923.xml · nonDerivative · entry 3 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 19:55 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $17.27 | $0.00 |
DisclosureSEC source: 0001415889-21-004480 · form4-09172021_120946.xml · derivative · entry 3 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 19:55 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
SaleCommon Stock, No Par Value | 10,000 | $72.01 | $720,100.00 |
DisclosureSEC source: 0001415889-21-004480 · form4-09172021_120946.xml · nonDerivative · entry 2 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,343 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $72.12, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 19:55 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
Exercise / conversionCommon Stock, No Par Value | 10,000 | $17.27 | $172,700.00 |
DisclosureSEC source: 0001415889-21-004480 · form4-09172021_120946.xml · nonDerivative · entry 1 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 19:53 UTC |
Ward Lynne N.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 14,867 | $0.00 Strike: $34.46 | $0.00 |
DisclosureSEC source: 0001415889-21-004479 · form4-09172021_120931.xml · derivative · entry 3 Ward Lynne · CIK 0001786127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,433 Underlying: Common Stock · 14,867 shares Expires 2026-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 08/28/2020. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 19:53 UTC |
Ward Lynne N.Director
|
SaleCommon Stock, No Par Value | 9,470 | $71.83 | $680,230.10 |
DisclosureSEC source: 0001415889-21-004479 · form4-09172021_120931.xml · nonDerivative · entry 2 Ward Lynne · CIK 0001786127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,499 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.538 to $72.02, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F2 · balance_after: The total reported in Column 5 of Table I includes 4,188 fully-vested restricted stock units and 2,914 restricted stock units that vest on June 17, 2022. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 19:53 UTC |
Ward Lynne N.Director
|
Exercise / conversionCommon Stock, No Par Value | 14,867 | $34.46 | $512,316.82 |
DisclosureSEC source: 0001415889-21-004479 · form4-09172021_120931.xml · nonDerivative · entry 1 Ward Lynne · CIK 0001786127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:52 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 3,636 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001415889-21-004419 · form4-09162021_040923.xml · derivative · entry 5 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,364 Underlying: Common Stock · 3,636 shares Expires 2024-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing on 04/14/2018. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:52 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
SaleCommon Stock, No Par Value | 3,454 | $71.76 | $247,859.04 |
DisclosureSEC source: 0001415889-21-004419 · form4-09162021_040923.xml · nonDerivative · entry 2 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,878 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.75 to $71.785, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:52 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
Exercise / conversionCommon Stock, No Par Value | 3,636 | $28.20 | $102,535.20 |
DisclosureSEC source: 0001415889-21-004419 · form4-09162021_040923.xml · nonDerivative · entry 1 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 23:08 UTC |
Anderson JillDirector
|
SaleCommon Stock, No Par Value | 850 | $71.64 | $60,894.00 |
DisclosureSEC source: 0001415889-21-004366 · form4-09132021_040939.xml · nonDerivative · entry 1 Anderson Jill · CIK 0001764314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,252 F1 · balance_after: The total reported in Column 5 of Table I includes 3,338 fully-vested restricted stock units and 2,914 restricted stock units that vest on June 17, 2022. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 20:48 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 2,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001415889-21-004345 · form4-09102021_010949.xml · derivative · entry 7 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,000 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 03/02/2019. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 20:48 UTC |
Parra Raul Jr.CFO AND TREASURER
|
SaleCommon Stock, No Par Value | 2,000 | $72.00 | $144,000.00 |
DisclosureSEC source: 0001415889-21-004345 · form4-09102021_010949.xml · nonDerivative · entry 4 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 20:48 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionCommon Stock, No Par Value | 2,000 | $44.80 | $89,600.00 |
DisclosureSEC source: 0001415889-21-004345 · form4-09102021_010949.xml · nonDerivative · entry 3 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 21:42 UTC |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $17.27 | $0.00 |
DisclosureSEC source: 0001415889-21-004349 · form4-09102021_020944.xml · derivative · entry 6 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Became exercisable in equal annual installments of 20% commencing 2/13/2016. F1 · ownership.nature: Represents securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.